FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Judith Falloon

Research Profile

Disorders

Living Beings

HIV-1

Chemicals & Drugs

Procedures

Anatomy

CD4-Positive T-Lymphocytes

Concepts & Ideas

Physiology

Mutation

Co-author Network

Publications

TOP 3
Dimitrios I Zonios; Judith Falloon; JOHN BENNETT; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen J Kovacs; Joseph A Kovacs; Richard Davey; H Clifford Lane; Henry Masur; Irini Sereti
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.
Dimitrios I Zonios; Judith Falloon; Chiung-Yu Huang; Doreen G Chaitt; JOHN BENNETT
Cryptococcosis and idiopathic CD4 lymphocytopenia.
Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony Fauci
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Judith Falloon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Dimitrios I Zonios; Judith Falloon; JOHN BENNETT; Pamela A Shaw; Doreen Chaitt; Michael W Baseler; Joseph W Adelsberger; Julia A Metcalf; Michael A Polis; Stephen J Kovacs; Joseph A Kovacs; Richard Davey; H Clifford Lane; Henry Masur; Irini Sereti
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors.
Blood 2008;112(2):287-94.
2007: Dimitrios I Zonios; Judith Falloon; Chiung-Yu Huang; Doreen G Chaitt; JOHN BENNETT
Cryptococcosis and idiopathic CD4 lymphocytopenia.
Medicine 2007;86(2):78-92.
2007: Angela Malaspina; Susan Moir; Doreen G Chaitt; Catherine A Rehm; Shyam Kottilil; Judith Falloon; Anthony Fauci
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7.
Blood 2007;109(5):2086-8.
2006: Sarah M Robertson; Elizabeth Formentini; Raul M Alfaro; Judith Falloon; Scott R Penzak
Lack of in vivo correlation between indinavir and saquinavir exposure and cytochrome P450 3A phenotype as assessed with oral midazolam as a phenotype probe.
Pharmacotherapy 2006;26(8):1051-9.
2006: Terrence W Brann; Robin L Dewar; Min-Kan Jiang; Akram Shah; Kunio Nagashima; Julia A Metcalf; Judith Falloon; H Clifford Lane; Tomozumi Imamichi
Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitness.
Journal of virology 2006;80(12):6136-45.
2006: Sarah M Robertson; Elizabeth Formentini; Raul M Alfaro; Ven Natarajan; Judith Falloon; Scott R Penzak
Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort.
British journal of clinical pharmacology 2006;61(4):379-88.
2006: Sarah Palmer; Valerie F Boltz; Frank Maldarelli; Mary Kearney; Elias K Halvas; Diane Rock; Judith Falloon; Richard Davey; Robin L Dewar; Julia A Metcalf; John W Mellors; John M Coffin
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.
AIDS (London, England) 2006;20(5):701-10.
2005: Joseph A Kovacs; Richard A Lempicki; Igor A Sidorov; Joseph W Adelsberger; Irini Sereti; William Sachau; Grace Kelly; Julia A Metcalf; Richard Davey; Judith Falloon; Michael A Polis; Jorge A Tavel; Randy Stevens; Laurie Lambert; Douglas A Hosack; Marjorie Bosche; Haleem J Issaq; Stephen D Fox; Susan F Leitman; Michael Baseler; Henry Masur; Michele Di Mascio; Dimiter S Dimitrov; H Clifford Lane
Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
The Journal of clinical investigation 2005;115(8):2139-48.
2005: Sarah Palmer; Mary Kearney; Frank Maldarelli; Elias K Halvas; Christian J Bixby; Holly Bazmi; Diane Rock; Judith Falloon; Richard Davey; Robin L Dewar; Julia A Metcalf; Scott Hammer; John W Mellors; John M Coffin
Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis.
Journal of clinical microbiology 2005;43(1):406-13.
2004: Camilo Jimenez; Stephanie A Moran; Irini Sereti; Sarah Wynne; Paul M Yen; Judith Falloon; Richard Davey; Nicholas Sarlis
Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection.
Thyroid : official journal of the American Thyroid Association 2004;14(12):1097-102.
2004: Stephen C De Rosa; Fabien X Lu; Joanne Yu; Stephen P Perfetto; Judith Falloon; Susan Moser; Thomas G Evans; Richard A Koup; Christopher J Miller; Mario Roederer
Vaccination in humans generates broad T cell cytokine responses.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(9):5372-80.
2004: Scott R Penzak; Jean M Shen; Raul M Alfaro; Alan T Remaley; Ven Natarajan; Judith Falloon
Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes.
Therapeutic drug monitoring 2004;26(3):322-30.
2003: Jorge A Tavel; Irini Sereti; Robert E Walker; Barbara Hahn; Joseph A Kovacs; Shyla Jagannatha; Richard Davey; Judith Falloon; Michael A Polis; Henry Masur; Julia A Metcalf; Randy Stevens; Adam Rupert; Michael Baseler; H Clifford Lane
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus.
The Journal of infectious diseases 2003;188(4):531-6.
2003: Kara B Anthony; Christian Yoder; Julia A Metcalf; Rebecca DerSimonian; Jan M Orenstein; Randy A Stevens; Judith Falloon; Michael A Polis; H Clifford Lane; Irini Sereti
Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
Journal of acquired immune deficiency syndromes (1999) 2003;33(2):125-33.
2003: Michael A Polis; Daniel L Suzman; Christian Yoder; Jean M Shen; JoAnn M Mican; Robin L Dewar; Julia A Metcalf; Judith Falloon; Richard Davey; Joseph A Kovacs; Mark B Feinberg; Henry Masur; Stephen C Piscitelli
Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.
AIDS (London, England) 2003;17(8):1167-72.
2003: Mounir Ait-Khaled; Abdelrahim Rakik; Philip Griffin; Chris Stone; Naomi Richards; Deborah Thomas; Judith Falloon; Margaret Tisdale
HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
Antiviral therapy 2003;8(2):111-20.
2002: Kirk D Miller; Henry Masur; Elizabeth C Jones; Galen O Joe; Margaret E Rick; Grace G Kelly; JoAnn M Mican; Shuying Liu; Lynn H Gerber; William C Blackwelder; Judith Falloon; Richard Davey; Michael A Polis; Robert E Walker; H Clifford Lane; Joseph A Kovacs
High prevalence of osteonecrosis of the femoral head in HIV-infected adults.
Annals of internal medicine 2002;137(1):17-25.
2002: Stephen C Piscitelli; Elizabeth Formentini; AH Burstein; Raul M Alfaro; Shyla Jagannatha; Judith Falloon
Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers.
Pharmacotherapy 2002;22(5):551-6.
2002: Jeffrey B Kopp; Judith Falloon; Armando C Filie; Andrea Abati; Christine King; Glen L Hortin; JoAnn M Mican; Ellen Vaughan; Kirk D Miller
Indinavir-associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(8):1122-8.
2002: Judith Falloon; Mounir Ait-Khaled; Deborah A Thomas; Carol L Brosgart; Joseph J Eron Jr; Judith Feinberg; Timothy P Flanigan; Scott M Hammer; Peter W Kraus; Robert Murphy; Ramon Torres; Henry Masur
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients.
AIDS (London, England) 2002;16(3):387-96.
2002: Stephen C Piscitelli; AH Burstein; Nada Welden; Keith Gallicano; Judith Falloon
The effect of garlic supplements on the pharmacokinetics of saquinavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(2):234-8.
2001: Joseph A Kovacs; Richard A Lempicki; Igor A Sidorov; Joseph W Adelsberger; Betsey Herpin; Julia A Metcalf; Irini Sereti; Michael A Polis; Richard Davey; Jorge A Tavel; Judith Falloon; Randy Stevens; Laurie Lambert; Robin L Dewar; DJ Schwartzentruber; M R Anver; Michael Baseler; Henry Masur; Dimiter S Dimitrov; H Clifford Lane
Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.
The Journal of experimental medicine 2001;194(12):1731-41.
2001: Joseph A Kovacs; S Vogel; Julia A Metcalf; Michael Baseler; Randy Stevens; Joseph W Adelsberger; Richard A Lempicki; Richard L Hengel; Irini Sereti; Laurie Lambert; Robin L Dewar; Richard Davey; Robert E Walker; Judith Falloon; Michael A Polis; Henry Masur; H Clifford Lane
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy.
European journal of immunology 2001;31(5):1351-60.
2001: Kirk D Miller; K Spooner; Betsey Herpin; Diane Rock Kress; Julia A Metcalf; Richard Davey; Judith Falloon; Joseph A Kovacs; Michael A Polis; Robert E Walker; Henry Masur; H Clifford Lane
Immunotherapy of HIV-infected patients with intermittent interleukin-2: effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion.
Clinical immunology (Orlando, Fla.) 2001;99(1):30-42.
2000: Tomozumi Imamichi; Steve C Berg; Hiromi Imamichi; J C Lopez; Julia A Metcalf; Judith Falloon; H Clifford Lane
Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.
Journal of virology 2000;74(23):10958-64.
2000: Joseph A Kovacs; Hiromi Imamichi; S Vogel; Julia A Metcalf; Robin L Dewar; Michael Baseler; Randy Stevens; Joseph W Adelsberger; Laurie Lambert; Richard Davey; Robert E Walker; Judith Falloon; Michael A Polis; Henry Masur; H Clifford Lane
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression.
The Journal of infectious diseases 2000;182(4):1063-9.
2000: Jan M Orenstein; Niranjan Bhat; Christian Yoder; C Fox; Michael A Polis; Julia A Metcalf; Joseph A Kovacs; Judith Falloon; Robert E Walker; Henry Masur; H Clifford Lane; Richard Davey
Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.
AIDS (London, England) 2000;14(12):1709-15.
2000: Robert E Walker; Chris Bechtel; Ven Natarajan; Michael Baseler; Kristen M Hege; Julia A Metcalf; Randy Stevens; A Hazen; R. Michael Blaese; C C Chen; Susan F Leitman; J Palensky; J Wittes; Richard Davey; Judith Falloon; Michael A Polis; Joseph A Kovacs; David F Broad; B L Levine; MR Roberts; Henry Masur; H Clifford Lane
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.
Blood 2000;96(2):467-74.
2000: Stephen C Piscitelli; AH Burstein; Doreen G Chaitt; Raul M Alfaro; Judith Falloon
Indinavir concentrations and St John's wort.
Lancet 2000;355(9203):547-8.
2000: Judith Falloon; Stephen C Piscitelli; S Vogel; B Sadler; Hiroaki Mitsuya; Mark F Kavlick; Kazuhisa Yoshimura; M Rogers; S LaFon; D J Manion; H Clifford Lane; Henry Masur
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):313-8.
2000: Judith Falloon
Salvage antiretroviral therapy.
AIDS (London, England) 2000;14 Suppl 3():S209-17.
2000: Tomozumi Imamichi; T Sinha; Hiromi Imamichi; YM Zhang; Julia A Metcalf; Judith Falloon; H Clifford Lane
High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.
Journal of virology 2000;74(2):1023-8.
1999: Richard Davey; Niranjan Bhat; Christian Yoder; Tae-Wook Chun; Julia A Metcalf; Robin L Dewar; Ven Natarajan; Richard A Lempicki; Joseph W Adelsberger; Kirk D Miller; Joseph A Kovacs; Michael A Polis; Robert E Walker; Judith Falloon; Henry Masur; Dennis Gee; Michael Baseler; Dimiter S Dimitrov; Anthony Fauci; H Clifford Lane
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(26):15109-14.
1999: Jan M Orenstein; Mark B Feinberg; Christian Yoder; L Schrager; JoAnn M Mican; DJ Schwartzentruber; Richard Davey; Robert E Walker; Judith Falloon; Joseph A Kovacs; Kirk D Miller; C Fox; Julia A Metcalf; Henry Masur; Michael A Polis
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient.
AIDS (London, England) 1999;13(16):2219-29.
1999: Scott M Whitcup; E Fortin; A S Lindblad; P Griffiths; Julia A Metcalf; Michael R Robinson; Jody Manischewitz; B Baird; C Perry; I M Kidd; Tamara R Vrabec; Richard Davey; Judith Falloon; Robert E Walker; Joseph A Kovacs; H Clifford Lane; Robert B Nussenblatt; J Smith; Henry Masur; Michael A Polis
Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
JAMA : the journal of the American Medical Association 1999;282(17):1633-7.
1999: Judith Falloon; S Sargent; Stephen C Piscitelli; Chris Bechtel; S W LaFon; B Sadler; Robert E Walker; Joseph A Kovacs; Michael A Polis; Richard Davey; H Clifford Lane; Henry Masur
Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study.
Pharmacotherapy 1999;19(9):1050-6.
1999: Kazuhisa Yoshimura; Ryohei Kato; K Yusa; Mark F Kavlick; Victor Maroun; A Nguyen; Tsutomu Mimoto; T Ueno; Makoto Shintani; Judith Falloon; Henry Masur; Hideya Hayashi; J Erickson; Hiroaki Mitsuya
JE-2147: a dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(15):8675-80.
1999: Judith Falloon
Time to genotype for selection of antiretroviral regimens in previously treated patients?
Lancet 1999;353(9171):2173-4.
1999: Richard Davey; Doreen G Chaitt; J M Albert; Stephen C Piscitelli; Joseph A Kovacs; Robert E Walker; Judith Falloon; Michael A Polis; Julia A Metcalf; Henry Masur; Robin L Dewar; Michael Baseler; Gwendolyn Fyfe; M A Giedlin; H Clifford Lane
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1999;179(4):849-58.
1999: Stephen C Piscitelli; G Kelly; Robert E Walker; J Kovacs; Judith Falloon; Richard Davey; Sangeeta Raje; Henry Masur; Michael A Polis
A multiple drug interaction study of stavudine with agents for opportunistic infections in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 1999;43(3):647-50.
1998: Stephen C Piscitelli; Stefanie N Vogel; William D Figg; Sangeeta Raje; A Forrest; Julia A Metcalf; Michael Baseler; Judith Falloon
Alteration in indinavir clearance during interleukin-2 infusions in patients infected with the human immunodeficiency virus.
Pharmacotherapy 1998;18(6):1212-6.
1998: Robert E Walker; C S Carter; Linda Muul; Ven Natarajan; Betsey Herpin; Susan F Leitman; HARVEY KLEIN; Craig A Mullen; Julia A Metcalf; Michael Baseler; Judith Falloon; Richard Davey; Joseph A Kovacs; Michael A Polis; Henry Masur; R. Michael Blaese; H Clifford Lane
Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults.
Nature medicine 1998;4(7):852-6.
1998: Kirk D Miller; E Jones; J A Yanovski; R Shankar; IM Feuerstein; Judith Falloon
Visceral abdominal-fat accumulation associated with use of indinavir.
Lancet 1998;351(9106):871-5.
1998: JC Gea-Banacloche; E E Weiskopf; Claire W Hallahan; J C López Bernaldo de Quirós; M Flanigan; JoAnn M Mican; Judith Falloon; Michael Baseler; Randy Stevens; H Clifford Lane; Mark Connors
Progression of human immunodeficiency virus disease is associated with increasing disruptions within the CD4+ T cell receptor repertoire.
The Journal of infectious diseases 1998;177(3):579-85.
1997: YM Zhang; Hiromi Imamichi; Tomozumi Imamichi; H Clifford Lane; Judith Falloon; M B Vasudevachari; N P Salzman
Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites.
Journal of virology 1997;71(9):6662-70.
1997: Michael A Polis; Stephen C Piscitelli; S Vogel; Frank G Witebsky; Patricia S Conville; Brent G Petty; Joseph A Kovacs; Richard Davey; Robert E Walker; Judith Falloon; Julia A Metcalf; C Craft; H Clifford Lane; Henry Masur
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection.
Antimicrobial agents and chemotherapy 1997;41(8):1709-14.
1997: J B Kopp; Kirk D Miller; J A Mican; IM Feuerstein; E Vaughan; C Baker; L K Pannell; Judith Falloon
Crystalluria and urinary tract abnormalities associated with indinavir.
Annals of internal medicine 1997;127(2):119-25.
1997: Mark Connors; Joseph A Kovacs; S Krevat; JC Gea-Banacloche; michael sneller; M Flanigan; Julia A Metcalf; Robert E Walker; Judith Falloon; Michael Baseler; IM Feuerstein; Henry Masur; H Clifford Lane
HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.
Nature medicine 1997;3(5):533-40.
1997: Richard Davey; Doreen G Chaitt; Stephen C Piscitelli; M Wells; Joseph A Kovacs; Robert E Walker; Judith Falloon; Michael A Polis; Julia A Metcalf; Henry Masur; Gwendolyn Fyfe; H Clifford Lane
Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.
The Journal of infectious diseases 1997;175(4):781-9.
1996: M B Vasudevachari; Y M Zhang; Hiromi Imamichi; T Imamichi; Judith Falloon; N P Salzman
Emergence of protease inhibitor resistance mutations in human immunodeficiency virus type 1 isolates from patients and rapid screening procedure for their detection.
Antimicrobial agents and chemotherapy 1996;40(11):2535-41.
1996: Joseph A Kovacs; S Vogel; J M Albert; Judith Falloon; Richard Davey; Robert E Walker; Michael A Polis; K Spooner; Julia A Metcalf; Michael Baseler; Gwendolyn Fyfe; H Clifford Lane
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.
The New England journal of medicine 1996;335(18):1350-6.
1996: Richard Davey; Doreen G Chaitt; G F Reed; William Freimuth; B R Herpin; Julia A Metcalf; P S Eastman; Judith Falloon; Joseph A Kovacs; Michael A Polis; Robert E Walker; Henry Masur; J Boyle; S Coleman; Steve R Cox; L Wathen; C L Daenzer; H Clifford Lane
Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 1996;40(7):1657-64.
1996: Robert E Walker; K M Spooner; G Kelly; R V McCloskey; J N Woody; Judith Falloon; Michael Baseler; Stephen C Piscitelli; Richard Davey; Michael A Polis; Joseph A Kovacs; Henry Masur; H Clifford Lane
Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1.
The Journal of infectious diseases 1996;174(1):63-8.
1996: Joseph A Kovacs; C Bechtel; Richard Davey; Judith Falloon; Michael A Polis; Robert E Walker; Julia A Metcalf; Victoria Davey; Stephen C Piscitelli; Michael Baseler; Robin L Dewar; N P Salzman; Henry Masur; H Clifford Lane
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trial.
The Journal of infectious diseases 1996;173(4):840-8.
1995: Michael A Polis; K M Spooner; B F Baird; J F Manischewitz; HS Jaffe; P E Fisher; Judith Falloon; Richard Davey; Joseph A Kovacs; Robert E Walker
Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.
Antimicrobial agents and chemotherapy 1995;39(4):882-6.
1995: Joseph A Kovacs; Michael Baseler; R J Dewar; S Vogel; Richard Davey; Judith Falloon; Michael A Polis; Robert E Walker; R Stevens; N P Salzman
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.
The New England journal of medicine 1995;332(9):567-75.
1994: Richard Davey; C M Boenning; B R Herpin; D H Batts; Julia A Metcalf; L Wathen; Steve R Cox; Michael A Polis; Joseph A Kovacs; Judith Falloon
Use of recombinant soluble CD4 Pseudomonas exotoxin, a novel immunotoxin, for treatment of persons infected with human immunodeficiency virus.
The Journal of infectious diseases 1994;170(5):1180-8.
1994: michael sneller; E M Eisenstein; Michael Baseler; H Clifford Lane; E T Donoghue; Judith Falloon
A unique syndrome of immunodeficiency and autoimmunity associated with absent T cell CD2 expression.
Journal of clinical immunology 1994;14(6):359-67.
1994: Judith Falloon; J Lavelle; D Ogata-Arakaki; A Byrne; A Graziani; A Morgan; M A Amantea; K Ownby; Michael A Polis; Richard Davey
Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
Antimicrobial agents and chemotherapy 1994;38(7):1580-7.
1994: H Clifford Lane; Barbara Laughon; Judith Falloon; Joseph A Kovacs; Richard Davey; Michael A Polis; Henry Masur
NIH conference. Recent advances in the management of AIDS-related opportunistic infections.
Annals of internal medicine 1994;120(11):945-55.
1993: Joseph A Kovacs; M B Vasudevachari; M Easter; Richard Davey; Judith Falloon; Michael A Polis; Julia A Metcalf; N Salzman; Michael Baseler; G E Smith
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.
The Journal of clinical investigation 1993;92(2):919-28.
1993: Richard Davey; Robin L Dewar; G F Reed; M B Vasudevachari; Michael A Polis; Joseph A Kovacs; Judith Falloon; Robert E Walker; Henry Masur; S E Haneiwich
Plasma viremia as a sensitive indicator of the antiretroviral activity of L-697,661.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(12):5608-12.
1993: Michael A Polis; M D deSmet; B F Baird; S Mellow; Judith Falloon; Richard Davey; Joseph A Kovacs; A G Palestine; Robert B Nussenblatt; Henry Masur
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet).
The American journal of medicine 1993;94(2):175-80.
1992: K M Zunich; H Clifford Lane; Richard Davey; Judith Falloon; Michael A Polis; Joseph A Kovacs; Henry Masur
Phase I/II studies of the toxicity and immunogenicity of recombinant gp160 and p24 vaccines in HIV-infected individuals.
AIDS research and human retroviruses 1992;8(8):1335.
1992: Judith Falloon
Current therapy for HIV infection and its infectious complications. A practical summary for primary care physicians.
Postgraduate medicine 1992;91(8):115-8, 123-6, 129-32.
1992: Richard Davey; L R Deyton; Julia A Metcalf; M Easter; Joseph A Kovacs; M Vasudevachari; M Psallidopoulos; L M Thompson; Judith Falloon; Michael A Polis
Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.
Journal of clinical immunology 1992;12(3):185-92.
1991: Judith Falloon; J Kovacs; WALTER HUGHES; D O'Neill; Michael A Polis; Richard Davey; M Rogers; S LaFon; IM Feuerstein; D Lancaster
A preliminary evaluation of 566C80 for the treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome.
The New England journal of medicine 1991;325(22):1534-8.
1991: A G Palestine; Michael A Polis; M D De Smet; B F Baird; Judith Falloon; Joseph A Kovacs; Richard Davey; J J Zurlo; K M Zunich; M Davis
A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.
Annals of internal medicine 1991;115(9):665-73.
1991: Richard Davey; Victoria Davey; Julia A Metcalf; J J Zurlo; Joseph A Kovacs; Judith Falloon; Michael A Polis; K M Zunich; Henry Masur; H Clifford Lane
A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1991;164(1):43-52.
1990: PA Pizzo; K Butler; FRANK BALIS; E Brouwers; M Hawkins; J Eddy; M Einloth; Judith Falloon; R Husson; Paul F Jarosinski
Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection.
The Journal of pediatrics 1990;117(5):799-808.
1990: H Clifford Lane; Victoria Davey; Joseph A Kovacs; J Feinberg; Julia A Metcalf; B Herpin; Robert E Walker; L Deyton; Richard Davey; Judith Falloon
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
Annals of internal medicine 1990;112(11):805-11.
1990: I M Feurestein; A Archer; James M Pluda; P S Francis; Judith Falloon; Henry Masur; Harvey I Pass; William D Travis
Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation.
Radiology 1990;174(3 Pt 1):697-702.
1989: Joseph A Kovacs; L Deyton; R Davey; Judith Falloon; K Zunich; D Lee; Julia A Metcalf; J W Bigley; L A Sawyer; Kathy Zoon
Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)
Annals of internal medicine 1989;111(4):280-7.
1989: Henry Masur; Frederick P Ognibene; R Yarchoan; J H Shelhamer; B F Baird; William D Travis; Anthony F Suffredini; L Deyton; Joseph A Kovacs; Judith Falloon
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
Annals of internal medicine 1989;111(3):223-31.
1989: H Clifford Lane; Judith Falloon; Robert E Walker; L Deyton; Joseph A Kovacs; Henry Masur; S Banks; L E Kirk; Michael Baseler; N P Salzman
Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
Annals of internal medicine 1989;111(1):41-50.
1989: FRANK BALIS; PA Pizzo; J Eddy; C Wilfert; R McKinney; Gwendolyn B Scott; R F Murphy; Paul F Jarosinski; Judith Falloon; David G Poplack
Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.
The Journal of pediatrics 1989;114(5):880-4.
1989: FRANK BALIS; PA Pizzo; R F Murphy; J Eddy; Paul F Jarosinski; Judith Falloon; S Broder; David G Poplack
The pharmacokinetics of zidovudine administered by continuous infusion in children.
Annals of internal medicine 1989;110(4):279-85.
1989: Judith Falloon; J Eddy; Lori S Wiener; PA Pizzo
Human immunodeficiency virus infection in children.
The Journal of pediatrics 1989;114(1):1-30.
1988: PA Pizzo; J Eddy; Judith Falloon; FRANK BALIS; R F Murphy; H Moss; Pamela L Wolters; Pim Brouwers; Paul F Jarosinski; M Rubin
Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection.
The New England journal of medicine 1988;319(14):889-96.